Pansend Life Sciences’ Portfolio Company, R2 Technologies, Receives Additional $10 Million Equity Investment From Huadong Medicine Company Limited
NEW YORK, April 23, 2020 (GLOBE NEWSWIRE) — HC2 Holdings, Inc. (“HC2”) (NYSE: HCHC), a diversified holding company, announced today […]